MOMO revenueFY2025CN¥10.37B
- FY YoY
- -1.9%
- 5Y CAGR
- -7.2%
MOMO revenue was CN¥10.37B for fiscal 2025 (ended Dec 31, 2025), down 1.9% from fiscal 2024. Compound annual growth was -7.2% over 5 years. It rose in 3 of the last 9 fiscal years.
Hello Group Inc. (MOMO) financials
For fiscal 2025 (ended Dec 31, 2025), Hello Group Inc. reported CN¥10.37B of revenue and CN¥804.01M of net income. Figures are in CNY, the currency of its SEC filings.
- Revenue, FY2025
- CN¥10.37B
- Revenue growth, YoY
- -1.9%
- Net income, FY2025
- CN¥804.01M
- Net income growth, YoY
- -22.7%
- Net margin
- 7.8%
- Free cash flow, FY2025
- CN¥690.59M
- EPS, diluted, FY2025
- CN¥2.37
- EPS growth, YoY
- -14.7%
- Cash
- CN¥5.32B
- Total debt
- CN¥5.25M
FY2016FY2025
FY2016FY2025
FY2016FY2025
MOMO revenue and earnings growth
MOMO net incomeFY2025CN¥804.01M
- FY YoY
- -22.7%
- 5Y CAGR
- -17.5%
MOMO net income was CN¥804.01M for fiscal 2025 (ended Dec 31, 2025), down 22.7% from fiscal 2024. Compound annual growth was -17.5% over 5 years. It rose in 1 of the last 3 fiscal years.
MOMO EPSFY2025CN¥2.37
- FY YoY
- -14.7%
- 5Y CAGR
- -13.3%
MOMO diluted EPS was CN¥2.37 for fiscal 2025 (ended Dec 31, 2025), down 14.7% from fiscal 2024. Compound annual growth was -13.3% over 5 years.
MOMO free cash flowFY2025CN¥690.59M
- FY YoY
- -49.0%
- 5Y CAGR
- -25.2%
MOMO free cash flow was CN¥690.59M for fiscal 2025 (ended Dec 31, 2025), down 49.0% from fiscal 2024. Compound annual growth was -25.2% over 5 years. It rose in 4 of the last 9 fiscal years.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥10.37B | CN¥10.56B | CN¥12.00B | CN¥12.70B | CN¥14.58B | CN¥15.02B | CN¥17.02B | CN¥13.41B | CN¥8.89B | CN¥3.71B |
| Cost of revenue | CN¥6.45B | CN¥6.45B | CN¥7.03B | CN¥7.42B | CN¥8.38B | CN¥7.98B | CN¥8.49B | CN¥7.18B | CN¥4.37B | CN¥1.62B |
| Gross profit | CN¥3.92B | CN¥4.12B | CN¥4.98B | CN¥5.28B | CN¥6.19B | CN¥7.05B | CN¥8.52B | CN¥6.23B | CN¥4.51B | CN¥2.09B |
| Research and development | - | - | - | - | CN¥1.13B | CN¥1.17B | CN¥1.10B | CN¥760.64M | CN¥346.14M | CN¥208.65M |
| Selling, general and admin | CN¥455.39M | CN¥507.66M | CN¥502.48M | CN¥596.01M | CN¥624.70M | CN¥763.15M | CN¥1.53B | CN¥640.02M | CN¥422.00M | CN¥259.71M |
| Operating income | CN¥1.35B | CN¥1.53B | CN¥2.31B | CN¥1.63B | -CN¥2.39B | CN¥2.53B | CN¥3.55B | CN¥3.27B | CN¥2.43B | CN¥975.09M |
| Interest expense | CN¥72.44M | CN¥127.85M | CN¥62.22M | CN¥83.53M | CN¥73.78M | CN¥78.87M | CN¥78.61M | CN¥56.50M | - | - |
| Pre-tax income | CN¥1.66B | CN¥1.83B | CN¥2.65B | CN¥2.03B | -CN¥2.10B | CN¥2.90B | CN¥3.87B | CN¥3.44B | CN¥2.55B | CN¥990.41M |
| Income tax | CN¥842.87M | CN¥845.02M | CN¥630.02M | CN¥562.28M | CN¥822.56M | CN¥755.62M | CN¥883.80M | CN¥699.65M | CN¥445.00M | CN¥34.64M |
| Net income | CN¥804.01M | CN¥1.04B | CN¥1.96B | CN¥1.48B | -CN¥2.91B | CN¥2.10B | CN¥2.97B | CN¥2.82B | CN¥2.15B | CN¥978.97M |
| EPS, basic | CN¥2.42 | CN¥2.81 | CN¥5.18 | CN¥3.80 | -CN¥7.20 | CN¥5.05 | CN¥7.15 | CN¥6.92 | CN¥5.44 | CN¥2.54 |
| EPS, diluted | CN¥2.37 | CN¥2.78 | CN¥4.92 | CN¥3.65 | -CN¥7.20 | CN¥4.83 | CN¥6.76 | CN¥6.59 | CN¥5.17 | CN¥2.41 |
| Diluted shares | 338.6M | 373.6M | 401.8M | 423.8M | 404.7M | 452.1M | 451.2M | 433.1M | 415.3M | 407.0M |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | CN¥5.32B | CN¥4.12B | CN¥5.62B | CN¥5.02B | CN¥5.57B | CN¥3.36B | CN¥2.61B | CN¥2.47B | CN¥4.46B | - |
| Short-term investments | CN¥124.71M | CN¥0 | CN¥0 | CN¥300.24M | CN¥0 | - | - | - | CN¥10.50M | - |
| Receivables | CN¥246.21M | CN¥192.32M | CN¥201.52M | CN¥188.71M | CN¥205.22M | CN¥200.83M | CN¥265.15M | CN¥719.61M | CN¥257.63M | - |
| Current assets | CN¥9.74B | CN¥12.01B | CN¥7.83B | CN¥11.72B | CN¥9.41B | CN¥11.75B | CN¥15.79B | CN¥12.63B | CN¥7.73B | - |
| Goodwill | CN¥596.30M | CN¥136.25M | CN¥0 | CN¥0 | CN¥0 | CN¥4.09B | CN¥4.36B | CN¥4.31B | CN¥22.13M | - |
| Total assets | CN¥13.78B | CN¥18.38B | CN¥16.23B | CN¥15.83B | CN¥18.11B | CN¥23.22B | CN¥22.48B | CN¥18.97B | CN¥8.47B | - |
| Current liabilities | CN¥2.08B | CN¥6.40B | CN¥2.09B | CN¥4.74B | CN¥2.52B | CN¥2.52B | CN¥2.61B | CN¥2.70B | CN¥1.69B | - |
| Short-term debt | CN¥2.12M | CN¥1.94B | CN¥0 | - | - | - | - | - | - | - |
| Long-term debt | CN¥3.13M | CN¥0 | CN¥1.94B | CN¥0 | - | - | - | - | - | - |
| Total debt | CN¥5.25M | CN¥1.94B | CN¥1.94B | CN¥0 | - | - | - | - | - | - |
| Total liabilities | CN¥2.69B | CN¥6.95B | CN¥4.24B | CN¥4.90B | CN¥7.53B | CN¥8.39B | CN¥8.76B | CN¥7.94B | CN¥1.72B | - |
| Shareholders' equity | CN¥11.08B | CN¥11.43B | CN¥11.99B | CN¥10.93B | CN¥10.59B | CN¥14.84B | CN¥13.72B | CN¥11.02B | CN¥6.75B | CN¥4.40B |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | CN¥1.18B | CN¥1.64B | CN¥2.28B | CN¥1.23B | CN¥1.56B | CN¥3.08B | CN¥5.45B | CN¥3.33B | CN¥2.89B | CN¥1.47B |
| Capital expenditures | CN¥492.52M | CN¥285.54M | CN¥576.31M | CN¥80.44M | CN¥95.32M | CN¥124.14M | CN¥186.52M | CN¥242.84M | CN¥218.63M | CN¥46.84M |
| Free cash flow | CN¥690.59M | CN¥1.35B | CN¥1.70B | CN¥1.15B | CN¥1.46B | CN¥2.96B | CN¥5.26B | CN¥3.08B | CN¥2.67B | CN¥1.42B |
| Investing cash flow | CN¥164.47M | -CN¥558.89M | CN¥2.41B | CN¥1.72B | CN¥2.55B | -CN¥748.47M | -CN¥4.03B | -CN¥10.03B | -CN¥188.17M | -CN¥800.92M |
| Financing cash flow | -CN¥5.44B | CN¥236.20M | -CN¥1.70B | -CN¥3.43B | -CN¥1.79B | -CN¥1.50B | -CN¥1.27B | CN¥4.69B | CN¥2.83M | CN¥124.0K |
| Share repurchases | CN¥749.98M | CN¥1.20B | CN¥212.19M | CN¥392.37M | CN¥862.87M | CN¥330.21M | - | - | - | - |
| Depreciation and amortization | CN¥81.81M | CN¥58.73M | CN¥79.61M | - | - | - | - | - | - | - |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -1.9% | -12.0% | -5.5% | -12.8% | -3.0% | -11.7% | 26.9% | 50.9% | 139.7% | - |
| Net income growth, YoY | -22.7% | -46.9% | 31.9% | - | - | -29.2% | 5.5% | 31.1% | 119.4% | - |
| EPS growth, YoY | -14.7% | -43.5% | 34.8% | - | - | -28.6% | 2.6% | 27.5% | 114.5% | - |
| Gross margin | 37.8% | 39.0% | 41.5% | 41.6% | 42.5% | 46.9% | 50.1% | 46.4% | 50.8% | 56.3% |
| Operating margin | 13.1% | 14.5% | 19.2% | 12.8% | -16.4% | 16.8% | 20.9% | 24.4% | 27.4% | 26.3% |
| Net margin | 7.8% | 9.8% | 16.3% | 11.7% | -20.0% | 14.0% | 17.5% | 21.0% | 24.2% | 26.4% |
| Free cash flow margin | 6.7% | 12.8% | 14.2% | 9.0% | 10.0% | 19.7% | 30.9% | 23.0% | 30.0% | 38.3% |
| Return on equity | 7.3% | 9.1% | 16.3% | 13.6% | -27.5% | 14.2% | 21.7% | 25.5% | 31.8% | 22.2% |
| Return on assets | 5.8% | 5.7% | 12.1% | 9.4% | -16.1% | 9.1% | 13.2% | 14.8% | 25.4% | - |
| Current ratio | 4.68 | 1.88 | 3.74 | 2.47 | 3.74 | 4.67 | 6.06 | 4.69 | 4.57 | - |
| Debt to equity | 0.00 | 0.17 | 0.16 | 0.00 | - | - | - | - | - | - |
Source: XBRL data Hello Group Inc. files with the SEC, latest filing dated Apr 28, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
MOMO peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| MOMO | CN¥10.37B | -1.9% | CN¥804.01M | 7.8% | $687.0M |
| MSFT | $346.44B | +17.9% | $142.63B | 41.2% | $4.05T |
| PLTR | $7.29B | +87.1% | $3.67B | 50.3% | $407.69B |
| ORCL | $71.78B | +21.6% | $18.92B | 26.4% | $362.21B |
| SAP | €36.80B | +7.7% | €7.16B | 19.5% | $291.67B |
| CRWD | $5.40B | +24.3% | $58.46M | 1.1% | $234.05B |
| SHOP | $14.17B | +32.5% | $2.13B | 15.0% | $195.63B |
| CRM | $43.94B | +11.2% | $9.66B | 22.0% | $176.90B |
| NOW | $15.43B | +21.8% | $1.45B | 9.4% | $106.66B |
MOMO FAQ
9 questionsWhat is MOMO revenue?
Hello Group Inc. (MOMO) reported CN¥10.37B of revenue for fiscal 2025 (ended Dec 31, 2025). That is down 1.9% from the year before.Is MOMO profitable?
Yes. Hello Group Inc. earned CN¥804.01M in net income for fiscal 2025 (ended Dec 31, 2025), a net margin of 7.8%.How much cash and debt does MOMO have?
Hello Group Inc. reported CN¥5.32B in cash and cash equivalents and CN¥5.25M of debt on its most recent balance sheet in SEC filings.How fast is MOMO revenue growing?
Hello Group Inc.'s revenue changed -1.9% in fiscal 2025, to CN¥10.37B. Its compound annual growth rate was -7.2% over 5 years.What is MOMO gross margin?
Hello Group Inc.'s gross profit was CN¥3.92B on CN¥10.37B of revenue for fiscal 2025 (ended Dec 31, 2025), a gross margin of 37.8%.What is MOMO free cash flow?
Hello Group Inc. generated CN¥690.59M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of CN¥1.18B less capital expenditures.What is MOMO earnings per share?
Diluted earnings per share were CN¥2.37 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did MOMO last report financial results?
The latest statements here come from Hello Group Inc.'s 20-F filed on Apr 28, 2026, covering the period ended Dec 31, 2025.Where does this MOMO financial data come from?
Quantisnow builds these statements from the structured XBRL data Hello Group Inc. files with the SEC. It is provided for information only and is not investment advice.